Biotech Hub

It is time for Medicare to move past legacy data storage and look to the incorporation of healthcare data platforms that provide beneficiaries with direct, unified access to their data and a way for…

The company received a warning letter on Wednesday related to inadequate quality requirements at the headquarters for its diabetes business. It comes after Medtronic expanded a recall of its MiniMed…

This is what we have known for years: medical care alone does not equal better health outcomes. Current research by the National Library of Medicine shows that medical care accounts for 10 to 20…

The startup is looking to help launch health plans by handling some of the administrative components. It bills itself as a tech-forward third-party administrator, and can help manage claims and…

Alison Singer explains why she is pushing for a new label, profound autism, to account for people like her daughter who need 24-hour care.

Bristol Myers Squibb has notched another FDA approval for its blockbuster immunology drug Orencia, this time for preventing acute graft versus host disease in bone marrow and stem cell transplant…

The company, which is building a cloud-based platform to help health systems pull health records together, recently closed a $150 million funding round.

Join STAT and industry experts for a recap of the event and a look at what we can expect across the field of hematology in the year ahead.

Biotech has always been perceived as ‘either a bubble or a disaster,” biotech investor Eli Casdin said at a recent STAT event in New York.

For virologists, immunologists, and vaccinologists, the future is coming into focus when it comes to Covid-19 boosters.